1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Research on China’s Animal Vaccine Industry, 2013-2017

Research on China’s Animal Vaccine Industry, 2013-2017

  • January 2013
  • -
  • Huidian Research
  • -
  • 85 pages

Animal vaccine sales amount in China was about CNY 7.11 billion (excluding net imports); the sales amount of swine vaccine and poultry vaccines were CNY 3.51 billion and 3.01 billion respectively, accounting for 49.4% and 42.3% of the total sales amount respectively. The market scale of China's animal vaccine is nearly CNY 10 billion in 2012.

Although there are nearly 60 animal vaccine manufacturers in China, the market share is concentrated in the hands of a few corporations. CAHIC, Qingdao Yebio Bioengineering Co. Ltd., Dahuanong, TECON and Chengdu TECBOND are the representatives of China’s animal vaccine industry. The five enterprises accounted for 37.9% of China’s animal vaccine market in the first half of 2012.

Among the key animal vaccine manufacturers in China, China Animal Husbandry Industry Co., Ltd (CAHIC) obtained the highest business income in the first half of 2012—CNY 964 million, accounting for 14.3% market share. TECON, Dahuanong and Jinyu Group also had more than 5% market share respectively. The sales of these companies mainly came from the national mandatory vaccine procurement policy. The proportion of the national mandatory vaccine procurement accounted for 82.7% of CAHIC’s total income in the first half of 2012.

In recent years, animal mandatory immunization coverage is gradually expanded in China. Restricted by the economic conditions, compulsory vaccination epidemics only cover five kinds of animal disease. While there are about 17 kinds of animal diseases; other diseases also have great hazard. With farming enterprises and farmers enhanced emphasis on the prevention and control of animal diseases, the demand of conventional vaccine at their own expense will be further improved in the future. Swine and poultry are the main species in China’s livestock breeding, newcastle disease vaccine and porcine circovirus vaccine will be the two conventional vaccines with very good market prospects.

Table Of Contents

Research on China’s Animal Vaccine Industry, 2013-2017
1. Development Environment of China's Animal Vaccine Industry
1.1 Market Characteristics
1.1.1 Industry Definition
1.1.2 Industry Characteristics
1.2 Economic Environment
1.2.1 Economic Development Status
1.2.2 GDP
1.2.3 Fixed Asset Investment
1.2.4 Import and Export Amount and Growth Rate
1.3 Policy Environment
1.3.1 Industry Related Policy
1.3.2 Effect of Related Policy

2. Technology Development of China's Animal Vaccine Industry
2.1 Product Technology Maturity
2.2 Technology Gap between China and Foreign Countries and Main Reasons
2.3 Strategy for Improving China's Technology

3. Development of China's Animal Vaccine Industry
3.1 Swine Vaccine
3.2 Poultry Vaccines
3.3 Pet Vaccines

4. Economic Operation of Animal Vaccine Industry
4.1 Industry Production and Sales, 2007-2012
4.2 Industry Scale, 2007-2012
4.3 Industry Profitability in 2011
4.4 Industry Business Development Capacity in 2011
4.5 Industry Debt Paying Ability in 2011

5. Import and Export of China's Animal Vaccine
5.1 Import
5.2 Export

6. Effect of Industry Competition Landscape on Investment in China, 2012
6.1 Michael Porter Five Forces Analysis of China's Animal Vaccine Industry
6.1.1 Competition between the Existing Enterprises
6.1.2 Potential New Entrant
6.1.3 Substitute
6.1.4 Bargaining Power of Supplier
6.1.5 Bargaining Power of Customers
6.2 Competition Landscape of China's Animal Vaccine Industry
6.3 Competition Forecast of China's Animal Vaccine Industry

7. Domestic Key Enterprises, 2011-2012
7.1 China Animal Husbandry Industry Co., Ltd. (CAHIC)
7.1.1 Company Profile
7.1.2 Business Performance
7.1.3 Company Competitiveness
7.1.4 Development Strategy
7.2 Inner Mongolia Jinyu Group Stock Company
7.2.1 Company Profile
7.2.2 Business Performance
7.2.3 Company Competitiveness
7.2.4 Development Strategy
7.3 TECON
7.3.1 Company Profile
7.3.2 Business Performance
7.3.3 Company Competitiveness
7.3.4 Development Strategy
7.4 Chengdu TECBOND Biological Products Co. Ltd.
7.4.1 Company Profile
7.4.2 Business Performance
7.4.3 Company Competitiveness
7.4.4 Development Strategy
7.5 Guangdong Dahuanong Animal Health Products Co. Ltd.
7.5.1 Company Profile
7.5.2 Business Performance
7.5.3 Company Competitiveness
7.5.4 Development Strategy

8. Investment Analysis of Animal Vaccine Industry, 2013-2017
8.1 Investment Opportunity
8.2 Investment Risk
8.2.1 Policy Risk
8.2.2 Market Risk
8.2.3 Application Risk
8.2.4 Technology Risk
8.3 Industry Barriers to Entry
8.3.1 Administrative Barriers to Entry
8.3.2 Technical Barrier
8.3.3 Brand Barrier
8.3.4 Management Barrier
8.3.5 Financial Barrier
8.4 Industry Investment Proposals

9. Investment Opportunity and Risk of Animal Vaccine Industry
9.1 Investment Opportunity of China's Animal Vaccine Industry
9.1.1 Investment Opportunity
9.1.2 Feasibility Study
9.2 Investment Efficiency of Animal Vaccine Industry
9.2.1 Investment Status in 2012
9.2.2 Investment Efficiency in 2012
9.2.3 Investment Trend Forecast 2013-2017
9.2.4 Investment Orientation, 2013-2017




Companies Mentioned

China Animal Husbandry Industry Co., Ltd. (CAHIC)
Inner Mongolia Jinyu Group Stock Company
TECON
Chengdu TECBOND Biological Products Co. Ltd.
Guangdong Dahuanong Animal Health Products Co. Ltd.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

  • $ 9 495
  • Industry report
  • May 2016
  • by Global Data

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis Summary GlobalData estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion ...

Virus Filtration Market by Product, Application, Devices, Air, Water Purification, End User - Global Forecast to 2020

Virus Filtration Market by Product, Application, Devices, Air, Water Purification, End User - Global Forecast to 2020

  • $ 5 650
  • Industry report
  • April 2016
  • by MarketsandMarkets

The global virus filtration market is projected to reach USD 3.25 billion by 2020 from USD 1.82 billion in 2015, at a CAGR of 12.3% between 2015 and 2020. By product, the market includes kits and reagents, ...

Viral Clearance Market by Application, Method, Detection & End User - Global Forecast to 2020

Viral Clearance Market by Application, Method, Detection & End User - Global Forecast to 2020

  • $ 5 650
  • Industry report
  • April 2016
  • by MarketsandMarkets

The global viral clearance market is projected to reach USD 510.3 million by 2020 from USD 285.5 million in 2015, at a CAGR of 12.3% from 2015 to 2020. The major drivers for the market include increase ...

Vaccines: The World Market

March 2016 $ 4 200

Download Unlimited Documents from Trusted Public Sources

Therapy and Antipsychotic Market in the UK

  • July 2016
    134 pages
  • Therapy  

    Antipsychotic  

    Hormone  

  • United Kingdom  

View report >

Therapy Market in Zimbabwe

  • July 2016
    7 pages
  • Biopharmaceutic...  

    Vaccine  

    Water Distribut...  

  • Zimbabwe  

    Africa  

View report >

Therapy Market in Brazil

  • July 2016
    6 pages
  • Vaccine  

    Rotavirus Vacci...  

  • Brazil  

View report >

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.